抑制剂-话题@MedSci

#抑制剂#

1990篇内容 | 2279人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1852756, encodeId=ee2d1852e5647, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=J Immunother Cancer：接受免疫检查点抑制剂治疗的癌症患者患肺结核的风险比普通人高 8 倍！, objectType=article, longId=217341, objectId=3de021e34127, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3de021e34127, replyNumber=0, likeNumber=66, createdTime=2022-01-30, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3de021e34127, moduleTitle=J Immunother Cancer：接受免疫检查点抑制剂治疗的癌症患者患肺结核的风险比普通人高 8 倍！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3de021e34127)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852747, encodeId=20541852e4774, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=Liver Cnacer：mTOR抑制剂Temsirolimus联合索拉非尼治疗晚期肝细胞癌的疗效和安全性：II期临床研究, objectType=article, longId=216786, objectId=af4a216e8623, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af4a216e8623, replyNumber=0, likeNumber=57, createdTime=2022-04-11, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af4a216e8623, moduleTitle=Liver Cnacer：mTOR抑制剂Temsirolimus联合索拉非尼治疗晚期肝细胞癌的疗效和安全性：II期临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af4a216e8623)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852578, encodeId=3c8418525e8ae, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=BMJ：质子泵抑制剂治疗持续性咽喉症状, objectType=article, longId=205635, objectId=dc2a20563534, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc2a20563534, replyNumber=0, likeNumber=91, createdTime=2021-06-12, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc2a20563534, moduleTitle=BMJ：质子泵抑制剂治疗持续性咽喉症状, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc2a20563534)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852625, encodeId=ef591852625c0, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=Nature Immunology：美国密西根大学邹伟平团队揭示MDM2-p53抑制剂肿瘤免疫学新机制, objectType=article, longId=209096, objectId=ca1f2090962d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca1f2090962d, replyNumber=0, likeNumber=86, createdTime=2021-11-10, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca1f2090962d, moduleTitle=Nature Immunology：美国密西根大学邹伟平团队揭示MDM2-p53抑制剂肿瘤免疫学新机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca1f2090962d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852598, encodeId=a5c81852598e5, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=Nat Chem Biol：Fbxo48抑制剂可通过阻止pAMPKα降解减轻胰岛素抵抗, objectType=article, longId=206568, objectId=0fba206568a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0fba206568a6, replyNumber=0, likeNumber=70, createdTime=2021-12-15, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0fba206568a6, moduleTitle=Nat Chem Biol：Fbxo48抑制剂可通过阻止pAMPKα降解减轻胰岛素抵抗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0fba206568a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852568, encodeId=eb1c185256845, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=NATURE：IspH抑制剂双管齐下杀灭革兰氏阴性菌, objectType=article, longId=204907, objectId=da5720490e26, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=da5720490e26, replyNumber=0, likeNumber=95, createdTime=2021-06-04, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=da5720490e26, moduleTitle=NATURE：IspH抑制剂双管齐下杀灭革兰氏阴性菌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=da5720490e26)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852636, encodeId=6b9a1852636f9, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=Stroke：SGLT2抑制剂对糖尿病肾病患者卒中和房颤的影响, objectType=article, longId=210247, objectId=eae121024e21, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eae121024e21, replyNumber=0, likeNumber=80, createdTime=2021-07-24, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eae121024e21, moduleTitle=Stroke：SGLT2抑制剂对糖尿病肾病患者卒中和房颤的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eae121024e21)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852751, encodeId=89271852e51ee, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=BMJ | 我国学者：使用抗精神病药物和胆碱酯酶抑制剂与跌倒和骨折的风险 , objectType=article, longId=216993, objectId=74b6216993ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74b6216993ba, replyNumber=0, likeNumber=75, createdTime=2022-07-12, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74b6216993ba, moduleTitle=BMJ | 我国学者：使用抗精神病药物和胆碱酯酶抑制剂与跌倒和骨折的风险 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74b6216993ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852643, encodeId=36dd1852643ec, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=Cardiovasc Diabetol：钠-葡萄糖共转运体抑制剂对CVD患者心血管、肾脏和安全预后的影响, objectType=article, longId=210820, objectId=58822108209b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58822108209b, replyNumber=0, likeNumber=112, createdTime=2021-05-28, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58822108209b, moduleTitle=Cardiovasc Diabetol：钠-葡萄糖共转运体抑制剂对CVD患者心血管、肾脏和安全预后的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=58822108209b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852778, encodeId=811a1852e78d7, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=BTK抑制剂tolebrutinib治疗多发性硬化症 (MS) ，显示出“有希望”的结果, objectType=article, longId=218566, objectId=6499218566f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6499218566f3, replyNumber=0, likeNumber=108, createdTime=2022-02-02, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6499218566f3, moduleTitle=BTK抑制剂tolebrutinib治疗多发性硬化症 (MS) ，显示出“有希望”的结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6499218566f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852766, encodeId=6a9b1852e6635, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=脱发有救了！JAK抑制剂巴瑞替尼可恢复80%头发生长，可能是斑秃的良药！, objectType=article, longId=218077, objectId=95b82180e746, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=95b82180e746, replyNumber=0, likeNumber=68, createdTime=2022-03-23, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=95b82180e746, moduleTitle=脱发有救了！JAK抑制剂巴瑞替尼可恢复80%头发生长，可能是斑秃的良药！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=95b82180e746)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852620, encodeId=c0441852620a4, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=JAMA Neurol：免疫检查点抑制剂相关脑炎特征研究, objectType=article, longId=208579, objectId=942d2085e962, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=942d2085e962, replyNumber=0, likeNumber=57, createdTime=2021-08-31, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=942d2085e962, moduleTitle=JAMA Neurol：免疫检查点抑制剂相关脑炎特征研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=942d2085e962)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852644, encodeId=900f185264472, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=Treadwell宣布利用PLK4抑制剂CFI-400945治疗白血病的1b/2期TWT-202研究已启动患者给药, objectType=article, longId=210883, objectId=0c032108832a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c032108832a, replyNumber=0, likeNumber=80, createdTime=2021-12-20, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c032108832a, moduleTitle=Treadwell宣布利用PLK4抑制剂CFI-400945治疗白血病的1b/2期TWT-202研究已启动患者给药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0c032108832a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852761, encodeId=695b1852e6125, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=Clin Gastroenterology H: STAT6变异与接受长期质子泵抑制剂治疗的患者的嗜酸性粒细胞性食管炎复发有关, objectType=article, longId=217646, objectId=910c21e6469c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=910c21e6469c, replyNumber=0, likeNumber=75, createdTime=2022-05-15, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=910c21e6469c, moduleTitle=Clin Gastroenterology H: STAT6变异与接受长期质子泵抑制剂治疗的患者的嗜酸性粒细胞性食管炎复发有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=910c21e6469c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852583, encodeId=5832185258380, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=FDA批准辉瑞ALK抑制剂克唑替尼新适应证：ALK阳性间变性大细胞淋巴瘤, objectType=article, longId=205805, objectId=fa1f20580549, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa1f20580549, replyNumber=0, likeNumber=0, createdTime=2021-01-20, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa1f20580549, moduleTitle=FDA批准辉瑞ALK抑制剂克唑替尼新适应证：ALK阳性间变性大细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa1f20580549)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852637, encodeId=597d185263e10, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=JACC：IL-6R抑制剂托珠单抗可有效改善急性STEMI患者的心肌挽救, objectType=article, longId=210381, objectId=578821038115, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=578821038115, replyNumber=0, likeNumber=96, createdTime=2021-08-01, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=578821038115, moduleTitle=JACC：IL-6R抑制剂托珠单抗可有效改善急性STEMI患者的心肌挽救, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=578821038115)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852765, encodeId=6da01852e652e, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=Ann Intern Med：SGLT2抑制剂 vs GLP-1 RA对有无CVD的T2D患者心血管事件风险的影响, objectType=article, longId=218049, objectId=35582180496e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35582180496e, replyNumber=0, likeNumber=66, createdTime=2022-05-26, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35582180496e, moduleTitle=Ann Intern Med：SGLT2抑制剂 vs GLP-1 RA对有无CVD的T2D患者心血管事件风险的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=35582180496e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852682, encodeId=f208185268223, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=J Immunother Cancer：体重指数、给药策略与免疫检查点抑制剂疗效的相关性, objectType=article, longId=212864, objectId=3add2128640c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3add2128640c, replyNumber=0, likeNumber=54, createdTime=2021-11-29, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3add2128640c, moduleTitle=J Immunother Cancer：体重指数、给药策略与免疫检查点抑制剂疗效的相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3add2128640c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852735, encodeId=7d3d1852e3541, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=Liver Cancer：肝细胞癌患者免疫检查点抑制剂（ICI）治疗期间使用抗生素缩短生存时间, objectType=article, longId=216031, objectId=4df92160316b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4df92160316b, replyNumber=0, likeNumber=71, createdTime=2021-11-13, rootId=0, userName=jklm09, userId=44a360, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4df92160316b, moduleTitle=Liver Cancer：肝细胞癌患者免疫检查点抑制剂（ICI）治疗期间使用抗生素缩短生存时间, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4df92160316b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1852781, encodeId=8a6c1852e8176, content=<a href='/topic/show?id=f0a254918f0' target=_blank style='color:#2F92EE;'>#抑制剂#</a>, objectTitle=Neurology：Andexanet Alfa在凝血因子Xa抑制剂相关性脑出血中的临床意义, objectType=article, longId=218655, objectId=6cb42186550a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6cb42186550a, replyNumber=0, likeNumber=65, createdTime=2021-12-07, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6cb42186550a, moduleTitle=Neurology：Andexanet Alfa在凝血因子Xa抑制剂相关性脑出血中的临床意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6cb42186550a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

抑制剂

2020-05-29

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

J Immunother Cancer：接受免疫检查点抑制剂治疗的癌症患者患肺结核的风险比普通人高 8 倍！

2022-01-30

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

Liver Cnacer：mTOR抑制剂Temsirolimus联合索拉非尼治疗晚期肝细胞癌的疗效和安全性：II期临床研究

2022-04-11

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

BMJ：质子泵抑制剂治疗持续性咽喉症状

2021-06-12

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

Nature Immunology：美国密西根大学邹伟平团队揭示MDM2-p53抑制剂肿瘤免疫学新机制

2021-11-10

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

Nat Chem Biol：Fbxo48抑制剂可通过阻止pAMPKα降解减轻胰岛素抵抗

2021-12-15

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

NATURE：IspH抑制剂双管齐下杀灭革兰氏阴性菌

2021-06-04

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

Stroke：SGLT2抑制剂对糖尿病肾病患者卒中和房颤的影响

2021-07-24

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

BMJ | 我国学者：使用抗精神病药物和胆碱酯酶抑制剂与跌倒和骨折的风险

2022-07-12

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

Cardiovasc Diabetol：钠-葡萄糖共转运体抑制剂对CVD患者心血管、肾脏和安全预后的影响

2021-05-28

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

BTK抑制剂tolebrutinib治疗多发性硬化症 (MS) ，显示出“有希望”的结果

2022-02-02

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

脱发有救了！JAK抑制剂巴瑞替尼可恢复80%头发生长，可能是斑秃的良药！

2022-03-23

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

JAMA Neurol：免疫检查点抑制剂相关脑炎特征研究

2021-08-31

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

Treadwell宣布利用PLK4抑制剂CFI-400945治疗白血病的1b/2期TWT-202研究已启动患者给药

2021-12-20

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

Clin Gastroenterology H: STAT6变异与接受长期质子泵抑制剂治疗的患者的嗜酸性粒细胞性食管炎复发有关

2022-05-15

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

FDA批准辉瑞ALK抑制剂克唑替尼新适应证：ALK阳性间变性大细胞淋巴瘤

2021-01-20

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

JACC：IL-6R抑制剂托珠单抗可有效改善急性STEMI患者的心肌挽救

2021-08-01

柳叶一刀 (审核中...)

前往app查看评论内容

#抑制剂#

Ann Intern Med：SGLT2抑制剂 vs GLP-1 RA对有无CVD的T2D患者心血管事件风险的影响

2022-05-26

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

J Immunother Cancer：体重指数、给药策略与免疫检查点抑制剂疗效的相关性

2021-11-29

jklm09 (审核中...)

前往app查看评论内容

#抑制剂#

Liver Cancer：肝细胞癌患者免疫检查点抑制剂（ICI）治疗期间使用抗生素缩短生存时间

2021-11-13

仁者大医 (审核中...)

前往app查看评论内容

#抑制剂#

Neurology：Andexanet Alfa在凝血因子Xa抑制剂相关性脑出血中的临床意义

2021-12-07

科室
- - 订阅+
  - 更多科室
工具
服务